Kevin Raymond Merrill Smith

Insider Reports History

Location
Marblehead, MA
Signature
/s/ Mary Wright, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Raymond Merrill Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inogen Inc CEO and President, Director Common Stock 86.3K $600K $6.95 Dec 1, 2025 Direct
Inogen Inc CEO and President, Director Restricted Stock Unit 28.3K $550K $9.71 Dec 1, 2025 Direct
ONCOSEC MEDICAL Inc Director Stock Option (Right to Buy) 25K Jun 28, 2021 Direct

Insider Reports Filed by Kevin Raymond Merrill Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INGN Inogen Inc Dec 1, 2025 3 -$96K 4 Dec 2, 2025 CEO and President, Director
INGN Inogen Inc Sep 1, 2025 1 $12K 4 Sep 3, 2025 CEO and President, Director
INGN Inogen Inc Feb 28, 2025 8 -$219K 4 Mar 4, 2025 CEO and President, Director
INGN Inogen Inc Dec 1, 2024 3 -$134K 4 Dec 3, 2024 CEO and President, Director
INGN Inogen Inc Mar 1, 2024 1 $0 4 Mar 5, 2024 CEO and President, Director
INGN Inogen Inc Nov 10, 2023 1 $0 4 Nov 13, 2023 CEO and President, Director
INGN Inogen Inc Nov 10, 2023 0 $0 3 Nov 13, 2023 CEO and President, Director
ONCS ONCOSEC MEDICAL Inc Jun 28, 2021 1 $0 4 Jun 29, 2021 Director